These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
657 related articles for article (PubMed ID: 34101213)
41. Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation. He FB; Khan H; Huttunen M; Kolehmainen P; Melén K; Maljanen S; Qu M; Jiang M; Kakkola L; Julkunen I Front Immunol; 2021; 12():694105. PubMed ID: 35069519 [TBL] [Abstract][Full Text] [Related]
42. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection. Mukherjee S; Banerjee B; Karasik D; Frenkel-Morgenstern M Viruses; 2021 Mar; 13(3):. PubMed ID: 33802569 [TBL] [Abstract][Full Text] [Related]
44. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027 [TBL] [Abstract][Full Text] [Related]
45. MDA5 cleavage by the Leader protease of foot-and-mouth disease virus reveals its pleiotropic effect against the host antiviral response. Pulido MR; Martínez-Salas E; Sobrino F; Sáiz M Cell Death Dis; 2020 Sep; 11(8):718. PubMed ID: 32879301 [TBL] [Abstract][Full Text] [Related]
46. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells. Yang S; Wu S; Yu Z; Huang J; Zhong X; Liu X; Zhu H; Xiao L; Deng Q; Sun W Immun Inflamm Dis; 2020 Dec; 8(4):753-762. PubMed ID: 33124193 [TBL] [Abstract][Full Text] [Related]
47. A SCID mouse-human lung xenograft model of SARS-CoV-2 infection. Fu W; Wang W; Yuan L; Lin Y; Huang X; Chen R; Cai M; Liu C; Chen L; Zhou M; Wu K; Zhao H; Pan D; Ma J; Hong J; Zhai B; Zhang Y; Kong Z; Wang Y; Chen Y; Yuan Q; Zhu H; Cheng T; Guan Y; Xia N Theranostics; 2021; 11(13):6607-6615. PubMed ID: 33995679 [TBL] [Abstract][Full Text] [Related]
48. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway. Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102 [TBL] [Abstract][Full Text] [Related]
49. RIG-I-like receptors direct inflammatory macrophage polarization against West Nile virus infection. Stone AEL; Green R; Wilkins C; Hemann EA; Gale M Nat Commun; 2019 Aug; 10(1):3649. PubMed ID: 31409781 [TBL] [Abstract][Full Text] [Related]
50. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination. Min YQ; Ning YJ; Wang H; Deng F J Biol Chem; 2020 Jul; 295(28):9691-9711. PubMed ID: 32471869 [TBL] [Abstract][Full Text] [Related]
51. ZFYVE1 negatively regulates MDA5- but not RIG-I-mediated innate antiviral response. Zhong X; Feng L; Zang R; Lei CQ; Yang Q; Shu HB PLoS Pathog; 2020 Apr; 16(4):e1008457. PubMed ID: 32251420 [TBL] [Abstract][Full Text] [Related]
52. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory. Carcaterra M; Caruso C Med Hypotheses; 2021 Jan; 146():110412. PubMed ID: 33308936 [TBL] [Abstract][Full Text] [Related]
53. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts. Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754 [TBL] [Abstract][Full Text] [Related]
54. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5. Zhang HL; Ye HQ; Liu SQ; Deng CL; Li XD; Shi PY; Zhang B J Virol; 2017 Sep; 91(18):. PubMed ID: 28659477 [TBL] [Abstract][Full Text] [Related]
55. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants. Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303 [TBL] [Abstract][Full Text] [Related]
56. Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study. Amado-Rodríguez L; Salgado Del Riego E; Gomez de Ona J; López Alonso I; Gil-Pena H; López-Martínez C; Martín-Vicente P; Lopez-Vazquez A; Gonzalez Lopez A; Cuesta-Llavona E; Rodriguez-Garcia R; Boga JA; Elena Alvarez-Arguelles M; Mayordomo-Colunga J; Vidal-Castineira JR; Crespo I; Fernandez M; Criado L; Salvadores V; Jimeno-Demuth FJ; Blanch L; Prieto B; Fernandez-Fernandez A; Lopez-Larrea C; Coto E; Albaiceta GM Elife; 2022 Jan; 11():. PubMed ID: 35060899 [TBL] [Abstract][Full Text] [Related]
57. MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade. Li Y; Yu P; Qu C; Li P; Li Y; Ma Z; Wang W; de Man RA; Peppelenbosch MP; Pan Q Antiviral Res; 2020 Apr; 176():104743. PubMed ID: 32057771 [TBL] [Abstract][Full Text] [Related]
58. The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity. Hage A; Bharaj P; van Tol S; Giraldo MI; Gonzalez-Orozco M; Valerdi KM; Warren AN; Aguilera-Aguirre L; Xie X; Widen SG; Moulton HM; Lee B; Johnson JR; Krogan NJ; García-Sastre A; Shi PY; Freiberg AN; Rajsbaum R Cell Rep; 2022 Mar; 38(10):110434. PubMed ID: 35263596 [TBL] [Abstract][Full Text] [Related]